Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.
Jco Precision Oncology
Carneiro, B A BA; Collier, K A KA; Nagy, R J RJ; Pamarthy, S S; Sagar, V V; Fairclough, S S; Odegaard, J J; Lanman, R B RB; Costa, R R; Taxter, T T; Kuzel, T M TM; Fan, A A; Chae, Y K YK; Cristofanilli, M M; Hussain, M H MH; Abdulkadir, S A SA; Giles, F J FJ